149 related articles for article (PubMed ID: 20435843)
1. PAI-1-derived peptide EEIIMD prevents impairment of cerebrovasodilation by augmenting p38 MAPK upregulation after cerebral hypoxia/ischemia.
Armstead WM; Riley J; Kiessling JW; Cines DB; Higazi AA
Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H76-80. PubMed ID: 20435843
[TBL] [Abstract][Full Text] [Related]
2. Novel plasminogen activator inhibitor-1-derived peptide protects against impairment of cerebrovasodilation after photothrombosis through inhibition of JNK MAPK.
Armstead WM; Riley J; Kiessling JW; Cines DB; Higazi AA
Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R480-5. PubMed ID: 20538898
[TBL] [Abstract][Full Text] [Related]
3. tPA contributes to impaired NMDA cerebrovasodilation after traumatic brain injury through activation of JNK MAPK.
Armstead WM; Kiessling JW; Riley J; Cines DB; Higazi AA
Neurol Res; 2011 Sep; 33(7):726-33. PubMed ID: 21756552
[TBL] [Abstract][Full Text] [Related]
4. PAI-1-derived peptide EEIIMD prevents hypoxia/ischemia-induced aggravation of endothelin- and thromboxane-induced cerebrovasoconstriction.
Armstead WM; Riley J; Cines DB; Higazi AA
Neurocrit Care; 2014 Feb; 20(1):111-8. PubMed ID: 24248736
[TBL] [Abstract][Full Text] [Related]
5. Salvinorin A pretreatment preserves cerebrovascular autoregulation after brain hypoxic/ischemic injury via extracellular signal-regulated kinase/mitogen-activated protein kinase in piglets.
Su D; Riley J; Armstead WM; Liu R
Anesth Analg; 2012 Jan; 114(1):200-4. PubMed ID: 22075021
[TBL] [Abstract][Full Text] [Related]
6. tPA contributes to impairment of ATP and Ca sensitive K channel mediated cerebrovasodilation after hypoxia/ischemia through upregulation of ERK MAPK.
Armstead WM; Riley J; Cines DB; Higazi AA
Brain Res; 2011 Feb; 1376():88-93. PubMed ID: 21182829
[TBL] [Abstract][Full Text] [Related]
7. Red blood cell-coupled tissue plasminogen activator prevents impairment of cerebral vasodilatory responses through inhibition of c-Jun-N-terminal kinase and potentiation of p38 mitogen-activated protein kinase after cerebral photothrombosis in the newborn pig.
Armstead WM; Ganguly K; Riley J; Kiessling JW; Cines DB; Higazi AA; Zaitsev S; Muzykantov VR
Pediatr Crit Care Med; 2011 Nov; 12(6):e369-75. PubMed ID: 21037505
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of integrin alphavbeta3 prevents urokinase plasminogen activator-mediated impairment of cerebrovasodilation after cerebral hypoxia/ischemia.
Kiessling JW; Cines DB; Higazi AA; Armstead WM
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H862-7. PubMed ID: 19168722
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activators contribute to impairment of hypercapnic and hypotensive cerebrovasodilation after cerebral hypoxia/ischemia in the newborn pig.
Armstead WM; Cines DB; Higazi AA
Stroke; 2005 Oct; 36(10):2265-9. PubMed ID: 16141421
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with glucagon and a novel plasminogen activator inhibitor-1-derived peptide enhances protection against impaired cerebrovasodilation during hypotension after traumatic brain injury through inhibition of ERK and JNK MAPK.
Armstead WM; Riley J; Cines DB; Higazi AA
Neurol Res; 2012 Jul; 34(6):530-7. PubMed ID: 22642975
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activators contribute to age-dependent impairment of NMDA cerebrovasodilation after brain injury.
Armstead WM; Cines DB; Higazie AA
Brain Res Dev Brain Res; 2005 May; 156(2):139-46. PubMed ID: 16099300
[TBL] [Abstract][Full Text] [Related]
12. NOC/oFQ activates ERK and JNK but not p38 MAPK to impair prostaglandin cerebrovasodilation after brain injury.
Ross J; Armstead WM
Brain Res; 2005 Aug; 1054(1):95-102. PubMed ID: 16099438
[TBL] [Abstract][Full Text] [Related]
13. Red blood cells-coupled tPA prevents impairment of cerebral vasodilatory responses and tissue injury in pediatric cerebral hypoxia/ischemia through inhibition of ERK MAPK activation.
Armstead WM; Ganguly K; Kiessling JW; Chen XH; Smith DH; Higazi AA; Cines DB; Bdeir K; Zaitsev S; Muzykantov VR
J Cereb Blood Flow Metab; 2009 Aug; 29(8):1463-74. PubMed ID: 19436314
[TBL] [Abstract][Full Text] [Related]
14. uPA impairs cerebrovasodilation after hypoxia/ischemia through LRP and ERK MAPK.
Armstead WM; Cines DB; Bdeir K; Kulikovskaya I; Stein SC; Higazi AA
Brain Res; 2008 Sep; 1231():121-31. PubMed ID: 18656457
[TBL] [Abstract][Full Text] [Related]
15. Urokinase plasminogen activator impairs SNP and PGE2 cerebrovasodilation after brain injury through activation of LRP and ERK MAPK.
Armstead WM; Christine AJ; Higazi AA; Cines DB
J Neurotrauma; 2008 Nov; 25(11):1375-81. PubMed ID: 19061381
[TBL] [Abstract][Full Text] [Related]
16. Salvinorin A administration after global cerebral hypoxia/ischemia preserves cerebrovascular autoregulation via kappa opioid receptor in piglets.
Wang Z; Ma N; Riley J; Armstead WM; Liu R
PLoS One; 2012; 7(7):e41724. PubMed ID: 22911847
[TBL] [Abstract][Full Text] [Related]
17. NOC/oFQ and NMDA contribute to piglet hypoxic ischemic hypotensive cerebrovasodilation impairment.
Armstead WM
Pediatr Res; 2002 May; 51(5):586-91. PubMed ID: 11978881
[TBL] [Abstract][Full Text] [Related]
18. PTK, MAPK, and NOC/oFQ impair hypercapnic cerebrovasodilation after hypoxia/ischemia.
Jagolino AL; Armstead WM
Am J Physiol Heart Circ Physiol; 2003 Jan; 284(1):H101-7. PubMed ID: 12485817
[TBL] [Abstract][Full Text] [Related]
19. Differential role of PTK, ERK and p38 MAPK in superoxide impairment of NMDA cerebrovasodilation.
Philip S; Armstead WM
Brain Res; 2003 Jul; 979(1-2):98-103. PubMed ID: 12850576
[TBL] [Abstract][Full Text] [Related]
20. Differential activation of ERK, p38, and JNK MAPK by nociceptin/orphanin FQ in the potentiation of prostaglandin cerebrovasoconstriction after brain injury.
Armstead WM
Eur J Pharmacol; 2006 Jan; 529(1-3):129-35. PubMed ID: 16352304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
